세계의 칼슘 채널 차단제 시장 보고서(2023년)

“Calcium Channel Blocker Global Market Report 2023 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on calcium channel blocker market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for calcium channel blocker? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The calcium channel blocker market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

• 1) By Drug Class: Dihydropyridine; Benzothizepine; Phenylalkylamine; Other Drug Classes

• 2) By Disease Indications: Hypertension; Chest Pain; Arrhythmias

• 3) By Route Of Administration: Oral; Parenteral; Other Route Of Administration

• 4) By End User: Hospitals; Homecare; Specialty Clinics; Other End Users

• Companies Mentioned: Pfizer Inc.; GSK Plc.; Novartis AG; Bausch Health Companies Inc.; Lupin Pharmaceuticals Inc.

• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

• Time series: Five years historic and ten years forecast.

• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

• Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Major players in the calcium channel blocker market are Pfizer Inc., GSK Plc., Novartis AG, Bausch Health Companies Inc., Lupin Pharmaceuticals Inc., Zydus Group, Covis Pharma BV, Mylan NV, Glenmark Pharmaceuticals Inc., Amneal Pharmaceuticals LLC, Sofgen Pharmaceuticals, Teva Pharmaceutical Industries Ltd., Knoll Healthcare Private Limited, Sanofi S.A, and Clearsynth.

The global calcium channel blocker market is expected to grow from $13.75 billion in 2022 to $14.66 billion in 2023 at a compound annual growth rate (CAGR) of 6.6%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The calcium channel blocker market is expected to grow to $18.60 billion in 2027 at a CAGR of 6.1%.

The calcium channel blocker market consists of sales of amlodipine, nicardipine, isradipine, diltiazem, and verapamil drugs. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

Calcium channel blockers refer to a type of drug that prevents calcium from entering the muscle cells of the heart and blood vessels. Calcium channel blockers are used to treat a variety of disorders, including high blood pressure, angina, and irregular heartbeats.

North America was the largest region in the calcium channel blocker market in 2022. The regions covered in the calcium channel blocker market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The drug types involved in calcium channel blockers are dihydropyridine, benzothizepine, phenylalkylamine, and others. Dihydropyridines refer to a class of drugs that block calcium channels in the heart and arterial blood vessel muscle cells, decreasing the number of calcium ions that can enter the cell. The disease indications involved are hypertension, chest pain and arrhythmias that are administrated by oral, parenteral, and other routes of administration and used by hospitals, homecare, specialty clinics, and other end users.

The increasing prevalence rate of cardiovascular diseases is expected to boost the growth of the calcium channel blocker market going forward. Cardiovascular disease refers to a type of condition that affects the heart or blood vessels. Calcium channel blockers (CCBs) are used to lower the risk of heart failure and stroke. Hence, the increasing prevalence rate of cardiovascular diseases will result in a rise in demand for the calcium channel blockers. For instance, according to a report published by the American Heart Association, a US-based organization dedicated to fighting heart disease and stroke, in 2020, cardiovascular disease (CVD) was responsible for about 19.1 million deaths globally. The age-adjusted mortality rate was 239.8 per 100,000 people. The age-adjusted prevalence rate was 7354.1 per 100,000. Eastern Europe and Central Asia had the highest rates of CVD-related mortality in 2020. Therefore, the increasing prevalence rate of cardiovascular diseases is driving the growth of the calcium channel blocker market.

Product innovation is the key trend gaining popularity in the calcium channel blocker market. Major companies operating in the calcium channel blockers market are focusing on developing innovative products to sustain their market position. For instance, in June 2022, CMP Pharma, a US-based pharmaceutical manufacturing company, launched Norliqva, the first and only oral liquid solution of the besylate salt of amlodipine, a long-acting calcium channel blocker. The unique feature of Norliqva is that it is an amlodipine liquid solution used to treat hypertension in people 6 years of age and older. Norliqva prevents the difficulties and irregularities of crushing or synthesizing amlodipine tablets and guarantees uniform dosing and bioequivalence. Norliqva is meant for a subset of patients who require amlodipine but have swallowing issues or are unable to swallow.

In September 2021, Azurity Pharmaceuticals Inc., a US-based specialty pharmaceutical company acquired Arbor Pharmaceuticals LLC for an undisclosed amount. The acquisition establishes a top business that provides cutting-edge, high-value goods to address the particular requirements of patients with underserved illnesses. Arbor Pharmaceuticals LLC is a US-based specialty pharmaceutical company offering calcium channel blocking agents.

The countries covered in the calcium channel blocker market report are: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The calcium channel blocker market research report is one of a series of new reports from The Business Research Company that provides calcium channel blocker market statistics, including calcium channel blocker industry global market size, regional shares, competitors with calcium channel blocker market share, detailed calcium channel blocker market segments, market trends, and opportunities, and any further data you may need to thrive in the calcium channel blocker industry. This calcium channel blocker market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Table of Contents

1. Executive Summary

2. Calcium Channel Blocker Market Characteristics

3. Calcium Channel Blocker Market Trends And Strategies

4. Calcium Channel Blocker Market - Macro Economic Scenario

• 4.1. COVID-19 Impact On Calcium Channel Blocker Market
• 4.2. Ukraine-Russia War Impact On Calcium Channel Blocker Market
• 4.3. Impact Of High Inflation On Calcium Channel Blocker Market

5. Calcium Channel Blocker Market Size And Growth

• 5.1. Global Calcium Channel Blocker Historic Market, 2017-2022, $ Billion
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints On The Market
• 5.2. Global Calcium Channel Blocker Forecast Market, 2022-2027F, 2032F, $ Billion
  • 5.2.1. Drivers Of The Market
  • 5.2.2. Restraints On the Market

6. Calcium Channel Blocker Market Segmentation

• 6.1. Global Calcium Channel Blocker Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• Dihydropyridine
• Benzothizepine
• Phenylalkylamine
• Other Drug Classes
• 6.2. Global Calcium Channel Blocker Market, Segmentation By Disease Indications, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• Hypertension
• Chest Pain
• Arrhythmias
• 6.3. Global Calcium Channel Blocker Market, Segmentation By Route Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• Oral
• Parenteral
• Other Route Of Administration
• 6.4. Global Calcium Channel Blocker Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• Hospitals
• Homecare
• Specialty Clinics
• Other End Users

7. Calcium Channel Blocker Market Regional And Country Analysis

• 7.1. Global Calcium Channel Blocker Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 7.2. Global Calcium Channel Blocker Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

8. Asia-Pacific Calcium Channel Blocker Market

• 8.1. Asia-Pacific Calcium Channel Blocker Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Calcium Channel Blocker Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 8.3. Asia-Pacific Calcium Channel Blocker Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

9. China Calcium Channel Blocker Market

• 9.1. China Calcium Channel Blocker Market Overview
• 9.2. China Calcium Channel Blocker Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
• 9.3. China Calcium Channel Blocker Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

10. India Calcium Channel Blocker Market

• 10.1. India Calcium Channel Blocker Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 10.2. India Calcium Channel Blocker Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

11. Japan Calcium Channel Blocker Market

• 11.1. Japan Calcium Channel Blocker Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 11.2. Japan Calcium Channel Blocker Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

12. Australia Calcium Channel Blocker Market

• 12.1. Australia Calcium Channel Blocker Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 12.2. Australia Calcium Channel Blocker Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

13. Indonesia Calcium Channel Blocker Market

• 13.1. Indonesia Calcium Channel Blocker Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 13.2. Indonesia Calcium Channel Blocker Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

14. South Korea Calcium Channel Blocker Market

• 14.1. South Korea Calcium Channel Blocker Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 14.2. South Korea Calcium Channel Blocker Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

15. Western Europe Calcium Channel Blocker Market

• 15.1. Western Europe Calcium Channel Blocker Market Overview
• 15.2. Western Europe Calcium Channel Blocker Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 15.3. Western Europe Calcium Channel Blocker Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

16. UK Calcium Channel Blocker Market

• 16.1. UK Calcium Channel Blocker Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 16.2. UK Calcium Channel Blocker Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

17. Germany Calcium Channel Blocker Market

• 17.1. Germany Calcium Channel Blocker Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 17.2. Germany Calcium Channel Blocker Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

18. France Calcium Channel Blocker Market

• 18.1. France Calcium Channel Blocker Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 18.2. France Calcium Channel Blocker Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

19. Eastern Europe Calcium Channel Blocker Market

• 19.1. Eastern Europe Calcium Channel Blocker Market Overview
• 19.2. Eastern Europe Calcium Channel Blocker Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 19.3. Eastern Europe Calcium Channel Blocker Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

20. Russia Calcium Channel Blocker Market

• 20.1. Russia Calcium Channel Blocker Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 20.2. Russia Calcium Channel Blocker Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

21. North America Calcium Channel Blocker Market

• 21.1. North America Calcium Channel Blocker Market Overview
• 21.2. North America Calcium Channel Blocker Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 21.3. North America Calcium Channel Blocker Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

22. USA Calcium Channel Blocker Market

• 22.1. USA Calcium Channel Blocker Market Overview
• 22.2. USA Calcium Channel Blocker Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 22.3. USA Calcium Channel Blocker Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

23. South America Calcium Channel Blocker Market

• 23.1. South America Calcium Channel Blocker Market Overview
• 23.2. South America Calcium Channel Blocker Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 23.3. South America Calcium Channel Blocker Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

24. Brazil Calcium Channel Blocker Market

• 24.1. Brazil Calcium Channel Blocker Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 24.2. Brazil Calcium Channel Blocker Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

25. Middle East Calcium Channel Blocker Market

• 25.1. Middle East Calcium Channel Blocker Market Overview
• 25.2. Middle East Calcium Channel Blocker Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 25.3. Middle East Calcium Channel Blocker Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

26. Africa Calcium Channel Blocker Market

• 26.1. Africa Calcium Channel Blocker Market Overview
• 26.2. Africa Calcium Channel Blocker Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 26.3. Africa Calcium Channel Blocker Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

27. Calcium Channel Blocker Market Competitive Landscape And Company Profiles

• 27.1. Calcium Channel Blocker Market Competitive Landscape
• 27.2. Calcium Channel Blocker Market Company Profiles
  • 27.2.1. Pfizer Inc.
    • 27.2.1.1. Overview
    • 27.2.1.2. Products and Services
    • 27.2.1.3. Strategy
    • 27.2.1.4. Financial Performance
  • 27.2.2. GSK Plc.
    • 27.2.2.1. Overview
    • 27.2.2.2. Products and Services
    • 27.2.2.3. Strategy
    • 27.2.2.4. Financial Performance
  • 27.2.3. Novartis AG
    • 27.2.3.1. Overview
    • 27.2.3.2. Products and Services
    • 27.2.3.3. Strategy
    • 27.2.3.4. Financial Performance
  • 27.2.4. Bausch Health Companies Inc.
    • 27.2.4.1. Overview
    • 27.2.4.2. Products and Services
    • 27.2.4.3. Strategy
    • 27.2.4.4. Financial Performance
  • 27.2.5. Lupin Pharmaceuticals Inc.
    • 27.2.5.1. Overview
    • 27.2.5.2. Products and Services
    • 27.2.5.3. Strategy
    • 27.2.5.4. Financial Performance

28. Key Mergers And Acquisitions In The Calcium Channel Blocker Market

29. Calcium Channel Blocker Market Future Outlook and Potential Analysis

30. Appendix

• 30.1. Abbreviations
• 30.2. Currencies
• 30.3. Historic And Forecast Inflation Rates
• 30.4. Research Inquiries
• 30.5. The Business Research Company
• 30.6. Copyright And Disclaimer